Dexcom G7 15 Day will first be available through durable medical equipment (DME) providers with full retail launch in the coming weeks. Designed to provide real-time glucose readings for an ...

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...

SEATTLE — On Tuesday evening, the northern lights blew up the skies from Washington state all the way to Florida, visible to the naked eye in many places. This type of strong geomagnetic storm, which ...

The peak of the rare, severe geomagnetic storm hit parts of the U.S. on Tuesday, November 11 at 8:20 p.m. ET, creating auroras as far south as Florida and prompting the National Oceanic and ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.